ADCI fundamentals
An in-depth look to ARAB PHARMACEUTICALS operating, investing, and financing activities
ADCI free cash flow for Q3 24 is 34.86 M EGP. For 2023, ADCI free cash flow was 23.6 M EGP and operating cash flow was 86.78 M EGP.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EGP
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM